OCUL Historical Earnings image   This OCUL historical earnings page last updated 8/10/2022
OCUL Historical Revenue
PeriodHistorical Earnings DateGAAP
Q2 20228/8/20220.01B
Q1 20225/9/20220.01B
Q4 20212/28/20220.01B
Q3 202111/8/20210.01B
Q2 20218/9/20210.01B
Q1 20215/5/20210.01B
Q4 20203/11/20210.01B
Q3 202011/5/20200.01B
Q2 20208/7/20200.00B
Q1 20205/8/20200.00B
Q4 20193/12/20200.00B
Q3 201911/12/20190.00B
Q2 20198/7/20190.00B
Q1 20195/10/20190.00B
Q4 20183/7/2019504000
Q3 201811/7/2018498000
Q2 20188/7/2018648000
Q1 20185/8/2018340000
Q4 20173/8/2018487000
Q3 201711/7/2017523000
Q2 20178/8/2017438000
Q1 20175/5/2017475000
Q4 20163/10/2017511000
Q3 201611/9/2016477000
Q2 20168/9/2016441000
Q1 20165/10/2016458000
Q4 20153/10/2016436000
Q3 201511/10/2015429000
Q2 20158/10/2015459000
Q1 20155/15/2015426000
Q4 20143/10/2015505000
Q3 201411/12/2014143000
Q2 20148/28/201497000
OCUL Historical Earnings EPS
PeriodHistorical Earnings DateGAAP
Q2 20228/8/2022-0.250
Q1 20225/9/2022-0.220
Q4 20212/28/2022-0.230
Q3 202111/8/2021-0.230
Q2 20218/9/2021-0.250
Q1 20215/5/2021-0.240
Q4 20203/11/2021-1.210
Q3 202011/5/2020-0.210
Q2 20208/7/2020-0.640
Q1 20205/8/2020-0.410
Q4 20193/12/2020-0.530
Q3 201911/12/2019-0.450
Q2 20198/7/2019-0.570
Q1 20195/10/2019-0.450
Q4 20183/7/2019-0.42
Q3 201811/7/2018-0.38
Q2 20188/7/2018-0.37
Q1 20185/8/2018-0.4
Q4 20173/8/2018-0.44
Q3 201711/7/2017-0.54
Q2 20178/8/2017-0.64
Q1 20175/5/2017-0.58
Q4 20163/10/2017-0.52
Q3 201611/9/2016-0.39
Q2 20168/9/2016-0.46
Q1 20165/10/2016-0.44
Q4 20153/10/2016-0.43
Q3 201511/10/2015-0.47
Q2 20158/10/2015-0.45
Q1 20155/15/2015-0.35
Q4 20143/10/2015-0.37
Q3 201411/12/2014-0.48
Q2 20148/28/2014-2.1
Quotes delayed 20 minutes

Email EnvelopeFree OCUL Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Ocular Therapeutix (OCUL) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

OCUP Historical Earnings
OCX Historical Earnings
ODT Historical Earnings
OFIX Historical Earnings
OGN Historical Earnings
OLMA Historical Earnings
OM Historical Earnings
OMER Historical Earnings
OMGA Historical Earnings
OMI Historical Earnings
What was the record high OCUL historical earnings result?
In terms of earnings or revenue, what is the best OCUL historical earnings result that Ocular Therapeutix has ever posted, and when?

✔️Accepted answer: Within our data set, the highest OCUL historical earnings result was set in Q3 2020, when Ocular Therapeutix posted results of -0.210/share. The most successful revenue quarter within our data set was Q1 2022 when Ocular Therapeutix reported revenue of 0.01B.

What was the lowest Ocular Therapeutix historical earnings result?
In terms of top line revenue or bottom line earnings per share, what was the lowest OCUL has reported, and when?

✔️Accepted answer: Within our data set, the lowest OCUL historical earnings result was set in Q2 2014, when Ocular Therapeutix posted results of -2.1/share. The smallest revenue quarter within our data set was Q2 2014 when Ocular Therapeutix reported revenue of 97000.

On this page we presented the OCUL historical earnings date information for Ocular Therapeutix. Reviewing that OCUL Historical Earnings for the company, we see that the highest historical earnings result in our data set was in Q3 2020, when OCUL posted gaap of -0.210/share. Meanwhile the lowest OCUL historical earnings result was in Q2 2014, when OCUL posted gaap of -2.1/share. Moving to Ocular Therapeutixs historical revenue numbers, the largest revenue quarter in our data set was seen in Q1 2022 when OCUL reported 0.01B in revenue, while the smallest revenue quarter was Q2 2014 when OCUL reported 97000 in revenue.

For self directed investors doing their due diligence on OCUL or any other given stock, their research can benefit from looking into all of the Ocular Therapeutix historical earnings in our data set presented side by side on one page for ease of comparison. Reviewing this historical EPS information can help when projecting future earnings per share, as well as providing important context for pondering whether the historical earnings trajectory justifies the current stock value or not. That's why we bring you HistoricalEarnings.com to make it more convenient for investors to look into Ocular Therapeutix historical earnings, or the historical earnings information for any stock in our coverage universe. In your continued due diligence investigations, we hope you check out the further links included for historical PE studies, earnings surprises history as well as next earnings dates for OCUL. Thanks for visiting, and the next time you need to research OCUL historical earnings or those of another stock, we hope our site will come to your mind as your preferred historical earnings, revenue, and EPS research resource of choice.

Recommended: IMNP Insider Buying, CXW Insider Buying, Funds Holding ELOX.

 

OCUL Historical Earnings | www.HistoricalEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.